EUVIMEDEUVIMED entdecken
CrossrefInfokarte

State- and Trait-Level Depressive Symptoms and Marijuana Use Among Urban Youth

Ricardo Zamarripa Ortega, Christopher Browning, Jodi L. Ford

Western Journal of Nursing Research · 2026-12 · 48 (12) · 1367-1376

DOI: 10.1177/01939459261497780 ↗
AbstractBibliografische Angaben

Abstract

Background: Marijuana is the most used illicit substance among youth, yet whether risk reflects stable or fluctuating depressive symptoms is unclear. Objective: This study examined whether state-level and trait-level depressive symptoms affect marijuana use, informing nurse-led screening and prevention. Methods: Guided by ecological systems theory, this secondary analysis of the Adolescent Health and Development in Context study used an ordered logistic regression model. Trait-level symptoms were each youth’s average over time; state-level symptoms, deviations from the average. The model adjusted for caregiver education, sex, race, and age across 3 levels: observations within youth within families. Results: We analyzed 2807 observations from 1516 youth, from 1456 households trait-level depressive symptoms (adjusted odds ratio [aOR] = 5.31; 95% confidence interval [CI], 2.82-10.00) and state-level symptoms (aOR = 2.70; 95% CI, 1.44-5.04) predicted higher frequency use. Male sex (aOR = 2.04; 95% CI, 1.16-3.60) and age (aOR = 1.79; 95% CI, 1.48-2.16) were significant. At age 12, any use was negligible; by age 18, up-to-twice-weekly use reached 13.3% for males and 7.3% for females at high trait-level symptoms. Conclusions: Trait-level symptoms carry the larger, chronic risk, while state-level elevations trigger additional short-term increase in use; interventions during acute distress may prevent escalation. Nurses can use depression screening to prevent use and flag underlying depression.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →